Can medication packaging improve glycemic control and blood pressure in type 2 diabetes? Results from a randomized controlled trial.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 10868823.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To assess the impact of calendar blister pack (CBP) use on glycemic and blood pressure control. We conducted an 8-month randomized controlled double-blind study among diabetic patients with poor glucose control (HbA1c >9.0%) in an urban area of South Auckland, New Zealand, with a high proportion of Maori and Pacific Islands people. Subjects included 68 consecutive patients, of whom 50% were prescribed three or more medications per day HbA1c was reduced by 0.95+/-0.22% in the CBP group and 0.15+/-0.25% in the control group (P = 0.026). Diastolic blood pressure decreased 5.8+/-1.5 mm Hg in the CBP group and increased 0.1+/-1.9 mm Hg in the control group (P = 0.0041). Systolic blood pressure did not change significantly CBPs should be considered among diabetic patients with poor glycemic control receiving multiple medications.
Medical subject headings
- Antihypertensive Agents
- Blood Pressure
- Diabetes Mellitus, Type 2
- Drug Packaging
- Hypoglycemic Agents